NEW YORK ( TheStreet) -- J&J's (JNJ - Get Report) most recent Tylenol and over-the-counter drug recall has been one of the hottest topics on the Internet after the company said that 2.5 million bottles could be affected by it.
Johnson & Johnson has been expanding its recall of OTC medicines including Tylenol, Motrin and Benadryl on Thursday and June 15 mainly due to a "musty or moldy odor."
"We shipped approximately 2.5 million bottles of the affected lots involved in yesterday's recall," said a company spokeswoman after widespread complaints about the company's lack of transparency about the latest recall,
reported on Friday.
Thursday's recall includes certain versions of Children's Tylenol, adult-strength Benadryl, Motrin IB, Tylenol Extra Strength, Tylenol Day & Night and Tylenol PM. The affected medicines were sold in America, Puerto Rico, Fiji, Guatemala, the Dominican Republic, Trinidad and Tobago, and Jamaica.
This is the
fifth recall in nine months
for J&J's McNeil Consumer Healthcare division, which had earlier declined to quantify the bottles of medicine included in the new recall. To date, the company has recalled at least 53 million bottles of popular over the counter medicine due to strange odors.
J&J stock has edged 0.1% lower to $60.487 one hour into Monday's regular trading session, in contrast with the broader equities which has been edging higher.
-- Reported by Andrea Tse in New York
| McNeil Recall Information
Get more stock ideas and investing advice on our sister site,
Follow Andrea Tse on
and become a fan on